Print Page  Close Window

Investor Relations
Corporate Profile

Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations.

Allscripts is one of the largest public companies focused exclusively on healthcare information technology globally. Allscripts offers healthcare providers, payers and life sciences companies globally a complete portfolio of clinical, financial, population health management, transaction and managed IT services and other solutions. As of December 31, 2016, we had approximately 7,600 employees worldwide. For 2016, revenue was $1.6 billion. We operate in 13 countries including Australia, Canada, India Israel and the United Kingdom.

Our industry leading client base of 180,000 physicians across approximately 45,000 ambulatory facilities, 2,500 hospitals and 17,000 post-acute organizations.

We invite investors to learn more about Allscripts and the impact we have on health care around the globe - To learn more, visit, Twitter, YouTube and It Takes A Community: The Allscripts Blog. Or please contact Seth R. Frank, Vice President of Investor Relations at

Recent NewsRSS Feeds | More >>
06/06/17Allscripts and GoodRx to empower providers in addressing prescription affordability
New partnership to provide drug price options at point of prescribing CHICAGO, June 06, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ:MDRX) and GoodRx have partnered to deliver a new solution that assists providers and patients in finding the best prescription price options and ultimately helps improve medication adherence. According to the CDC, in order to save money, nearly 8% of American adults don’t take their medicine as prescribed. And with deductibles having increased forty-nine perce... 
Printer Friendly Version
06/05/172bPrecise Collaborates with Mayo Clinic to Develop and Apply Genomics-Based Clinical Decision Support Tools
June 05, 2017 09:00 AM Eastern Daylight Time PITTSBURGH--(BUSINESS WIRE)--2bPrecise, LLC, an EHR-agnostic, cloud-based precision medicine platform, today announced a technology license agreement with Mayo Clinic as well as a collaboration to develop and research genomics-based care protocols. Leveraging the unique functionality of the 2bPrecise platform and Mayo Clinic’s know-how and electronic phenotyping algorithms, 2bPrecise will incorporate these n... 
Printer Friendly Version
05/30/17Allscripts achieves full 2015 edition certification across all EHRs with Drummond Group LLC
Allscripts Sunrise™ first acute EHR to successfully deliver certified 2015 technology; Allscripts TouchWorks® EHR achieves full certification by completing G2 Object Measure Certification CHICAGO, May 30, 2017 (GLOBE NEWSWIRE) -- ­­Through its partnership with Drummond Group LLC, Allscripts (NASDAQ:MDRX) newest versions of Sunrise and TouchWorks EHR are now certified for the 2015 Edition requirements that support Modified Meaningful Use (MU) Stage 2, Meaningful Use Stage 3, Advancing Care Inf... 
Printer Friendly Version
05/24/17Allscripts names new director
Shareholders elect biotech industry executive Mara G. Aspinall; all current Allscripts directors re-elected CHICAGO, May 24, 2017 (GLOBE NEWSWIRE) -- Allscripts shareholders elected Mara G. Aspinall to serve as director. Aspinall is president and CEO of Health Catalysts, an investment and advisory firm dedicated to the growth of new healthcare companies. Aspinall is also executive chairman of GenePeeks, a computational genomics company, and is a member of the Board of Directors of Abcam plc (... 
Printer Friendly Version
EventsMore >>
06/06/17 9:05 a.m. ET
Allscripts at Robert W. Baird & Co. Global Consumer, Technology & Services Conference
06/07/17 10:30 a.m. ET
Allscripts at Jefferies 2017 Global Healthcare Conference
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources